Tylenol w/ codeine and Omniscan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tylenol w/ codeine (acetaminophen; codeine phosphate) and Omniscan (gadodiamide). Common drug interactions include nephrogenic systemic fibrosis among females and mobility decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Tylenol w/ codeine and Omniscan. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Tylenol w/ codeine?

Tylenol w/ codeine has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 8,107 Tylenol w/ codeine users. Check the latest studies of Tylenol w/ codeine.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.



On Jul, 12, 2026

24 people who take Tylenol w/ codeine and Omniscan together, and have interactions are studied.

Tylenol w/ codeine and Omniscan drug interactions.

What are the common drug interactions of Tylenol W/ Codeine and Omniscan, by gender? *:

female:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Mobility decreased (ability to move is reduced)
  3. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  4. Skin fibrosis (fibrous tissue formation on skin)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Skin hyperpigmentation (disorders affect the colour of your skin)
  7. Skin induration (an abnormally hard spot or area on the skin)
  8. Rash
  9. Oedema peripheral (superficial swelling)
  10. Oedema (fluid collection in tissue)

male:

  1. Mobility decreased (ability to move is reduced)
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Emotional distress
  4. Gait disturbance
  5. Injury
  6. Joint contracture (a permanent shortening of a muscle or joint)
  7. Joint range of motion decreased (disease of joint movement)
  8. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  9. Muscle contracture (a permanent shortening of a muscle)
  10. Muscle tightness

What are the common drug interactions of Tylenol W/ Codeine and Omniscan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Deformity (disfigurement)
  3. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  4. Fatigue (feeling of tiredness)
  5. General physical health deterioration (weak health status)
  6. Mobility decreased (ability to move is reduced)
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  9. Rash papular (redness with papule)
  10. Scar

40-49:

  1. Skin hypopigmentation (loss of skin colour)
  2. Skin ulcer
  3. Anxiety
  4. Emotional distress
  5. General physical health deterioration (weak health status)
  6. Injury
  7. Joint swelling
  8. Lower extremity mass (mass in lower legs)
  9. Mobility decreased (ability to move is reduced)
  10. Muscle spasms (muscle contraction)

50-59:

  1. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Skin fibrosis (fibrous tissue formation on skin)
  4. Skin hyperpigmentation (disorders affect the colour of your skin)
  5. Skin induration (an abnormally hard spot or area on the skin)
  6. Mobility decreased (ability to move is reduced)
  7. Oedema (fluid collection in tissue)
  8. Oedema peripheral (superficial swelling)
  9. Scar
  10. Skin exfoliation (removal of the oldest dead skin cells)

60+:

  1. Gait disturbance
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Emotional distress
  4. Injury
  5. Joint contracture (a permanent shortening of a muscle or joint)
  6. Joint range of motion decreased (disease of joint movement)
  7. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  8. Mobility decreased (ability to move is reduced)
  9. Muscle contracture (a permanent shortening of a muscle)
  10. Muscle tightness

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Brain: 16 people, 66.67%
  2. High Blood Cholesterol: 13 people, 54.17%
  3. Stress And Anxiety: 12 people, 50.00%
  4. Nausea (feeling of having an urge to vomit): 12 people, 50.00%
  5. Itching: 12 people, 50.00%
  6. Herpes Zoster: 12 people, 50.00%
  7. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 50.00%
  8. Device Related Infection: 12 people, 50.00%
  9. Depression: 12 people, 50.00%
  10. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 7 people, 29.17%

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol w/ codeine and Omniscan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tylenol w/ codeine and Omniscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tylenol w/ codeine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omniscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol w/ codeine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omniscan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; codeine phosphate and gadodiamide (the active ingredients of Tylenol w/ codeine and Omniscan, respectively), and Tylenol w/ codeine and Omniscan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: